After a few months of intermittent fasting, the body’s resistance to insulin drops by a measurable amount, making it easier for cells to absorb sugar from the blood.
Scientific Claim
Intermittent fasting reduces HOMA-IR by 0.31 units in adults with metabolic syndrome over interventions averaging 3 months, demonstrating a statistically significant improvement in insulin resistance.
Original Statement
“HOMA-IR decreased by 0.31 on an average (95% CIs: −0.44; −0.19)”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The claim reflects the exact reported effect size and confidence interval. The causal verb is justified by the RCT-based meta-analysis design.
Evidence from Studies
Supporting (1)
Unknown Title
This study found that people with metabolic syndrome who tried intermittent fasting had a 0.31-point drop in a common measure of insulin resistance, and this drop was big enough to be real—not just due to chance.